在日本开发患者和医生之间的沟通工具,以识别COPD恶化
Paul Jones1, Osamu Hataji2, Yoshimi Suzukamo3
1GSK, Brentford, Middlesex, UK.
COPD
|July 13, 2023
概括
一个新的工具,日本的慢性阻塞性肺病恶化识别工具 (CERT-J),被开发来帮助日本患者更好地识别恶化. 这个简单的工具专注于关键症状,如呼吸困难,咳和.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
- 患者报告的结果
背景情况:
- 慢性阻塞性肺病 (COPD) 的恶化在日本经常被低估.
- 这种报告不足可能源于患者对恶化症状的认知不足.
- 需要一种文化特定的工具来改善日本COPD患者的恶化识别.
研究的目的:
- 开发和验证一个简单的工具,日本慢性阻塞性肺病恶化识别工具 (CERT-J),用于识别日本患者的恶化.
- 确定日本患者用来描述恶化的关键症状和短语.
主要方法:
- 针对COPD和喘-COPD重叠患者 (n=41) 进行了焦点小组,以收集症状描述.
- 进行了认知解读和项目改进.
- 探索性因素分析 (EFA) 指导专家小组为CERT-J选择项目,在100名患者中进行了测试.
主要成果:
- 最终的CERT-J包括六个项目,重点关注呼吸困难和活动限制 (3项),咳 (1项) 和 (2项).
- 呼吸困难成为EFA的主要因素.
- 确定了11个与呼吸困难或活动限制有关的项目,其中7个得到了高度认可.
结论:
- CERT-J是一种新的,简单的工具,旨在提高日本患者对COPD恶化的识别.
- 通过CERT-J来更好地识别恶化预计将有利于患者的理解和管理.
- 该工具的开发涉及患者的投入和严格的统计分析,以确定临床相关性.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
249
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
249
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K